Bliss GVS Pharma Ltd.
BSE: 506197 | Sector: Health care |
NSE: BLISSGVS | ISIN Code: INE416D01022 |
BSE 00:00 | 09 Apr | 101.35 |
0.95 (0.95%) |
OPEN
100.85 |
HIGH
102.50 |
LOW
96.65 |
NSE 00:00 | 09 Apr | 101.35 |
1.00 (1.00%) |
OPEN
101.00 |
HIGH
103.00 |
LOW
100.35 |
OPEN | 100.85 |
PREVIOUS CLOSE | 100.40 |
VOLUME | 252458 |
52-Week high | 224.00 |
52-Week low | 86.00 |
P/E | 13.98 |
Mkt Cap.(Rs cr) | 1,045 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bliss GVS Pharma Ltd. (BLISSGVS) - Yearly Result
Particulars (![]() |
Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
Net Sales/Income From Operations | 441.95 | 426.59 | 297.89 | 348.02 | 326.38 |
Other Income | 34.93 | 35.81 | 11.00 | 8.63 | 23.08 |
Total Income | 476.88 | 462.40 | 308.89 | 356.64 | 349.46 |
Total Expenditure | 341.78 | 333.49 | 209.43 | 247.04 | 229.87 |
Operating Profit | 135.10 | 128.91 | 99.46 | 109.61 | 119.59 |
Interest | 4.56 | 3.15 | 6.95 | 9.07 | 13.53 |
Gross Profit | 130.54 | 125.76 | 92.51 | 100.53 | 106.06 |
Depreciation | 8.83 | 5.75 | 5.67 | 5.62 | 5.85 |
PBT | 121.71 | 120.01 | 86.83 | 94.90 | 100.20 |
Tax | 31.91 | 45.44 | 30.20 | 35.72 | 33.47 |
Net Profit/(Loss) | 92.33 | 74.43 | 57.01 | 59.13 | 65.61 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 92.33 | 74.43 | 57.01 | 59.13 | 65.61 |
Equity Share Capital | 10.31 | 10.31 | 10.31 | 10.31 | 10.31 |
Reserves Excluding Revaluation Reserves | 672.63 | 592.96 | 531.11 | 481.33 | 421.76 |
EPS | |||||
Basic EPS | 8.95 | 7.22 | 5.53 | 5.73 | 6.36 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices